Jaggy Rao, MD* , MD Division of Dermatology, University of Alberta Edmonton, Alberta, Canada

 

Preliminary Study

To evaluate the safety, tolerability and effectiveness of transdermal Hyaluronic Acid (HA) delivery using Dermelectroporation®

Study Design

  • 10 healthy female subjects
  • Symmetrical periorbital rhytids
  • Randomization: Only RIGHT or LEFT face treated
  • Efficacy Parameters:
    – Photography
    – Histology
    – Blinded dermatologist assessment
    – Subject questionnaires

 

Materials and Methods

Materials

  • Hyaluronic Acid 15 mg/ml, very low viscosity from Apothécure, Inc., Dallas, Texas
  • Ultrapeel® + TransDerm Ionto® from Mattioli Engineering, Florence, Italy

Methods

  • Side to be treated scrubbed with acetone
  • Periorbital region treated with microdermabrasion
  • 3.0 milliliters of HA transdermally delivered per Tx approximately 5 – 10 minutes per session (Picture 2)
  • Two transdermal treatments given, 2 weeks apart
  • Mupirocin ointment immediately post-treatment
  • 2 mm punch biopsies at 4 weeks post-treatment

Results

  • Minimal and transient side effects
    – erythema (10), mild abrasions (6), purpura (1)
  • All subjects tolerated the treatments well
    – average Tolerability Score = 2.2*
  • Subject questionnaires
    – average Improvement Score = 3.2**
    • 1 = no discomfort,
    • 2 = mild discomfort,
    • 3 = moderate discomfort,
    • 4 = severe discomfort
    ** 1 = no improvement, 2 = mild improvement, 3 = moderate improvement, and 4 = dramatic improvement
  • Average change in Wrinkle Class (1 – 5) *
    – Treated Side = – 1.3
    – Control Side = – 0.2
  • Pre- and 4-week follow-up photos evaluated by four independent blinded physician observers
    – Average improvement treated side = 3.3 **
    – Average improvement control side = 1.2 **
    * As determined by blinded dermatologist reviewer
    ** 1 = no improvement,
    2 = mild improvement,
    3 = moderate improvement,
    4 = dramatic improvement

Conclusions and Implications

  • Through Dermoelectroporation®, transdermal drug delivery of HA is possible and safe
  • This concept may improve the efficiency of other biological agents and drugs such as anesthetics, anti inflammatory, and photosensitizers
  • New studies are in progress to further examine the potential scope of this process

Leave a Reply

Your email address will not be published. Required fields are marked *